Author:
Djingarey Mamoudou H.,Barry Rodrigue,Bonkoungou Mete,Tiendrebeogo Sylvestre,Sebgo Rene,Kandolo Denis,Lingani Clement,Preziosi Marie-Pierre,Zuber Patrick L.F.,Perea William,Hugonnet Stéphane,Dellepiane de Rey Tolve Nora,Tevi-Benissan Carole,Clark Thomas A.,Mayer Leonard W.,Novak Ryan,Messonier Nancy E.,Berlier Monique,Toboe Desire,Nshimirimana Deo,Mihigo Richard,Aguado Teresa,Diomandé Fabien,Kristiansen Paul A.,Caugant Dominique A.,LaForce F. Marc
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference18 articles.
1. A review of vaccine research and development: meningococcal disease;Girard;Vaccine,2006
2. WHO. Joint recommendations for the development and introduction of conjugate vaccines against meningococcal disease in the African and Eastern Mediterranean Regions, April 2000.
3. Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine;LaForce;Health Affairs,2011
4. Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands;De Greef;Pediatr Infect Dis J,2006
5. Global Advisory Committee on Vaccine Safety, 3–4 December 2009;WHO;Weekly Epid Rec,2010